Clinical trials
Completed Adenocarcinoma trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Adenocarcinoma of Lung | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Ductal | 1 |
| Carcinoma, Large Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Intestinal Neoplasms | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.